---
$id: https://graph.org.ai/products/commodity/51414102
$type: Product
source: UNSPSC
code: "51414102"
title: "Etofylline nicotinate"
class: "51414100"
classTitle: "Vasodilator purines"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etofylline nicotinate

**UNSPSC Code**: 51414102
**Class**: [Vasodilator purines](Vasodilator purines.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vasodilating agent with the molecular formula C15H15N5O4, chemically known as 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)ethyl pyridine-3-carboxylate but generally known as Etofylline nicotinate, which bears US NIH Compound Identifier 83435. European Medicines Agency schedules Etofylline nicotinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07324MIG. World Health Organization schedules regadenoson in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule etofylline nicotinate under HS 29395900 and SITC 54145. As of Q4 2014, ETOFYLLINE NICOTINATE remains the US FDA Preferred Term for this commodity. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCOC(=O)C3=CN=CC=C3.

